Stem cell collection may predict MDS risk in myeloma patients

08/22/2013 | MyelomaBeacon.com

The risk of developing myelodysplastic syndrome was more than three times greater for myeloma patients who receive transplants of stem cells gathered after an initial transplant compared with cases where the stem cells were collected beforehand, according to a study from the University of Arkansas for Medical Sciences. Overall, the timing of stem cell collection did not affect survival, researchers reported in the journal Leukemia.

View Full Article in:

MyelomaBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC